Granulation Design in Tablet Formulation

Granulation Design in Tablet Formulation

In pharmaceutical R&D, wet granulation is a fundamental process, especially for oral solid dosage forms where flow, compressibility, or uniformity challenges exist. One of the most critical early decisions during formulation development is the choice of granulating solvent—either aqueous or alcoholic—as this directly impacts product stability, impurity levels, granule integrity, and manufacturing scalability. Below is…

Innovator Product Testing for Drug Product Development
|

Innovator Product Testing for Drug Product Development

Every successful generic drug starts with one essential step — understanding the innovator. Innovator Product Testing is where science meets strategy. Before formulation begins, this stage provides a complete technical blueprint of the reference product. Here’s what it entails: 1. Physical Testing — More Than Just Dimensions We analyze the innovator tablet for: These parameters…

Sourcing of Raw Materials for Formulation Development

Sourcing of Raw Materials for Formulation Development

In generic drug development, the materials you source dictate everything downstream—from formulation consistency and regulatory approval to long-term commercial viability. “Your sourcing strategy is not just a procurement exercise—it’s a regulatory foundation.” Here’s what a smart, compliant, and inspection-ready sourcing strategy looks like: 1. Use Only Commercial-Grade Raw Materials Why it matters? Using research-grade or…

FDA Inactive Ingredient Database (IID) | A Hidden Asset in Generic Drug Development

FDA Inactive Ingredient Database (IID) | A Hidden Asset in Generic Drug Development

In generic drug development, every excipient decision matters—not just for performance, but for regulatory approval. One of the most underrated tools we have is the FDA Inactive Ingredient Database (IID). The IID isn’t just a list. It’s a strategic database that gives you regulatory confidence while selecting excipients. It contains excipients that are already approved…

Why Every Great Generic Drug Begins with a Literature Search?

Why Every Great Generic Drug Begins with a Literature Search?

In pharmaceutical development, what you know before you start determines how far—and how fast—you go. The Handbook of Pharmaceutical Generic Development underscores the literature search as the first strategic pillar of generic drug development. It’s not just academic—it’s operational intelligence. Here’s what a high-quality literature search accomplishes: Establishes the Regulatory Landscape Knowing the regulatory path…

Critical Quality Attributes (CQAs) in Formulation Development
|

Critical Quality Attributes (CQAs) in Formulation Development

In pharmaceutical development, understanding your Critical Quality Attributes (CQAs) is not just regulatory jargon — it’s the foundation of Quality by Design (QbD). According to ICH Q8(R2), a CQA is any physical, chemical, biological, or microbiological characteristic that must be controlled within an appropriate range to ensure the desired product quality. These attributes have a…

End of content

End of content